Cargando…

MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer

Approximately half of the colorectal cancer (CRC) patients develop metastatic disease. Fluoropyrimidine-based chemotherapy forms the backbone of treatment in these patients. However, the response to this therapy varies between individuals. Therefore, an important challenge in CRC research is to iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simmer, Femke, Venderbosch, Sabine, Dijkstra, Jeroen R., Vink-Börger, Elisa M., Faber, Claudius, Mekenkamp, Leonie J., Koopman, Miriam, De Haan, Anton F., Punt, Cornelis J., Nagtegaal, Iris D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673216/ https://www.ncbi.nlm.nih.gov/pubmed/26392389

Ejemplares similares

Reduced rate of copy number aberrations in mucinous colorectal carcinoma
por: Hugen, Niek, et al.
Publicado: (2015)

EMAST Is Associated with a Poor Prognosis in Microsatellite Instable Metastatic Colorectal Cancer
por: Venderbosch, Sabine, et al.
Publicado: (2015)

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
por: Mekenkamp, Leonie JM, et al.
Publicado: (2012)

Mitochondrial microsatellite instability in patients with metastatic colorectal cancer
por: Venderbosch, S., et al.
Publicado: (2015)

High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue
por: Tol, Jolien, et al.
Publicado: (2010)

Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their Primary Counterparts and Differences Are Typically Non-Recurrent
por: Mekenkamp, Leonie J. M., et al.
Publicado: (2014)

RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps
por: van Herwaarden, Yasmijn J, et al.
Publicado: (2020)

Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer
por: Punt, C.J.A., et al.
Publicado: (2023)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
por: Knijn, N, et al.
Publicado: (2011)

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials
por: Goey, Kaitlyn K H, et al.
Publicado: (2017)

MicroRNA expression in formalin-fixed paraffin embedded tissue using real time quantitative PCR: the strengths and pitfalls
por: Dijkstra, J R, et al.
Publicado: (2012)

Fluoropyrimidine-induced cardiotoxicity
por: Deac, Andrada Larisa, et al.
Publicado: (2020)

Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients
por: de Ridder, Jannemarie, et al.
Publicado: (2016)

Genomic landscape of metastatic colorectal cancer
por: Haan, Josien C., et al.
Publicado: (2014)

Incidental findings in the bowel cancer population screening program: other polyps and malignancies – A nationwide study
por: Nagtegaal, Iris D, et al.
Publicado: (2022)

Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?
por: Knikman, Jonathan E., et al.
Publicado: (2020)

Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study
por: te Groen, Maarten, et al.
Publicado: (2023)

Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer
por: Bokhorst, John-Melle, et al.
Publicado: (2023)

Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020)

The puzzling clinical presentation of fluoropyrimidines cardiotoxicity
por: Cucciniello, Linda, et al.
Publicado: (2022)

Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients
por: de Bitter, Tessa J. J., et al.
Publicado: (2022)

Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature
por: Venderbosch, Sabine, et al.
Publicado: (2011)

Antitumor Activity of Fluoropyrimidines and Thymidylate Synthetase Inhibition
por: Kubota, Tetsuro, et al.
Publicado: (1991)

Cardiotoxicity of Fluoropyrimidines: Epidemiology, Mechanisms, Diagnosis, and Management
por: Jurczyk, Michał, et al.
Publicado: (2021)

The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)
por: ’t Lam - Boer, Jorine, et al.
Publicado: (2014)

Limited impact of the COVID-19 pandemic on colorectal cancer care in the Netherlands in 2020
por: Meijer, Joyce, et al.
Publicado: (2022)

Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014
por: Punt, Cornelis JA, et al.
Publicado: (2015)

Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
por: Xue, Angli, et al.
Publicado: (2018)

Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study
por: Bosch, Steven L., et al.
Publicado: (2019)

Umbilical metastases: Real‐world data shows abysmal outcome
por: Hugen, Niek, et al.
Publicado: (2021)

A review on the importance of genotyping and phenotyping in fluoropyrimidine treatment
por: Deac, Andrada-Larisa, et al.
Publicado: (2020)

Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
por: Grumetti, Laura, et al.
Publicado: (2022)

Recommendations for reporting histopathology studies: a proposal
por: Knijn, N., et al.
Publicado: (2015)

Fluoropyrimidine combination therapy versus fluoropyrimidine monotherapy for gemcitabine-refractory advanced pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials
por: Tian, Wei, et al.
Publicado: (2023)

Intra-Tumoral Genomic Heterogeneity in Rectal Cancer: Mutational Status Is Dependent on Preoperative Biopsy Depth and Location
por: Vuijk, Floris A., et al.
Publicado: (2021)

Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis
por: Marchetti, S, et al.
Publicado: (2001)

A narrative review of genetic factors affecting fluoropyrimidine toxicity
por: Gmeiner, William H.
Publicado: (2021)

Contents of Volume 143
Publicado: (2010)

Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients
por: Jongeneel, Gabrielle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0u7gdp7r8icahghca5lkvr872m